IL-15 ADMINISTRATION FOLLOWING SYNGENEIC MURINE BONE-MARROW TRANSPLANTATION (BMT) FOR LYMPHOMA IMPROVES SURVIVAL AND HAS DECREASED TOXICITYWHEN COMPARED TO IL-2

Authors
KATSANIS E XU Z PANOSKALTSISMORTARI A HASZ DE WEISDORF DJ WIDMER MB BLAZAR BR
Citation
E. Katsanis et al., IL-15 ADMINISTRATION FOLLOWING SYNGENEIC MURINE BONE-MARROW TRANSPLANTATION (BMT) FOR LYMPHOMA IMPROVES SURVIVAL AND HAS DECREASED TOXICITYWHEN COMPARED TO IL-2, Blood, 86(10), 1995, pp. 2272-2272
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
86
Issue
10
Year of publication
1995
Supplement
1
Pages
2272 - 2272
Database
ISI
SICI code
0006-4971(1995)86:10<2272:IAFSMB>2.0.ZU;2-J